Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

FORMULE G8 LIQ 1.5% 1.5 % — DIN 00438758

L-EPHEDRINE HYDROCHLORIDE : 1.5 % · HERBAGES NATURBEC LTÉE. · LIQUID · wholesale supply in Canada

Health Canada status: CANCELLED POST MARKET

What is FORMULE G8 LIQ 1.5%?

FORMULE G8 LIQ 1.5% 1.5 % contains L-EPHEDRINE HYDROCHLORIDE : 1.5 %. It is listed in the Health Canada Drug Product Database under DIN 00438758, held by HERBAGES NATURBEC LTÉE., supplied as LIQUID for NASAL administration. Health Canada currently lists it as cancelled post market, status dated 04-Jul-2008. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.

How much does Ephedrine cost around the world?

Ephedrine is listed on 2 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.

What a market publishes matters more than the number it publishes. Morocco publishes a PPV (public price); United Kingdom publishes a hospital. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.

MarketPrice basis published thereBrandsPacks listedRange
United Kingdomhospital55GBP███.██
MoroccoPPV (public price)22MAD███.██

7 pack listings across 7 brand entries and 2 price bases, refreshed 05 Sep 2026. Ranges span every Ephedrine pack in that market, so a high figure is usually a larger pack rather than the same product.

Figures are held for the Nexara team. Cross-market prices are published on incompatible bases and are not an offer, a landed cost, or a guide to what any buyer can obtain. Nexara publishes which markets list the product and on what basis; the numbers stay internal.

Team sign-in

This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.

How is it supplied and stored?

Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.

Strength on the label1.5 %
Dosage formLIQUID
RouteNASAL

Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.

Substance and classification

Active substanceEphedrine
ATC codeR01AA03
AHFS class12:12.12
Biosimilar biologicNo

Health Canada record and identifiers

The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.

DIN (8-digit, as used in ordering)00438758
DIN (unpadded, as printed on some documents)438758
Brand nameFORMULE G8 LIQ 1.5%
Generic / active ingredientL-EPHEDRINE HYDROCHLORIDE : 1.5 %
Market authorization holderHERBAGES NATURBEC LTÉE.
Health Canada scheduleNON-PRESCRIPTION DRUGS
ATC codeR01AA03
ATC anatomical main groupR — Respiratory system
ATC therapeutic subgroupR01AA
Current statusCANCELLED POST MARKET
Status date04-Jul-2008
Original market date1979-12-31 00:00:00
Status sourceLive Health Canada DPD sync

Verify on the primary sources

Health Canada DPD record

What can be used instead?

Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.

2 · Same class — other molecules in ATC R01AA

MoleculeCanadian brandsDINsMarketedSourceable
OxymetazolineAESB - OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTION USP, 0.025% · AFRIN COLD · CLARITIN ALLERGY DECONGESTANT · COOLING MENTHOL NASAL SPRAY · +34 more4213Yes
XylometazolineBALMINIL DECONGEST · BALMINIL NASAL DECONGESTANT · CERTIFIED DECONGESTANT NASAL SPRAY .1% · COLD & ALLERGY RELIEF · +24 more315Yes
PhenylephrineNEO SYNEPHRINE NASAL DROP 1% · NEO-SYNEPHRINE NASAL DROP 1%20Not in Canada
EphedrineFORMULE G8 LIQ 1.5%10Not in Canada

A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.

3 · Adjacent classes in ATC R01A

ATC subgroupMoleculesDINsMarketed
R01ADBeclomethasone · Budesonide · Ciclesonide · Flunisolide · Fluticasone · +5 more5524
R01AXCombinations · Ipratropium Bromide · Various424
R01ABEphedrine · Naphazoline · Oxymetazoline · Phenylephrine121
R01ACCromoglicic Acid · Levocabastine60

Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.

What else is FORMULE G8 LIQ 1.5% called?

The same molecule, Ephedrine, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:

NameScriptRegistered in
CAUSTINERF ARSENICALLatinMorocco
YRANICID ARSENICAL PATELatinMorocco

Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.

Can this still be bought in Canada?

No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.

If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Why is there no price on this page?

Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Sources and disclaimer

Product data sourced from the Health Canada Drug Product Database. Health Canada status reconciled against the live DPD sync. Last reviewed 10 Sep 2026.

Nothing on this page is medical advice. Nexara Health is a licensed wholesale distributor and supplies licensed entities only; consumer orders are routed to a partner pharmacy. Alternatives tables describe supply, not clinical equivalence.

Health Canada Drug Product Database (DPD), DIN 00438758. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.